MiMedx Group (MDXG) Projected to Post Earnings on Wednesday

MiMedx Group (NASDAQ:MDXG) is anticipated to release its earnings data after the market closes on Wednesday, February 26th. Analysts expect MiMedx Group to post earnings of $0.07 per share and revenue of $89.42 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

MiMedx Group Price Performance

NASDAQ:MDXG opened at $7.95 on Tuesday. MiMedx Group has a one year low of $5.47 and a one year high of $10.14. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10. The firm has a market cap of $1.17 billion, a price-to-earnings ratio of 14.45 and a beta of 1.94. The firm’s fifty day moving average is $8.81 and its two-hundred day moving average is $7.67.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, MiMedx Group currently has a consensus rating of “Buy” and a consensus price target of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.